How many patents does
Santaris Pharma have?
patents
807
families
86
granted
161
applications
646
US
177
EP
119
WO
79
JP
38
KR
36
CN
31
GB
3
RoW
324
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Santaris Pharma
Top ten assignees appearing on patents
2009 - 2018
2009
| santaris pharma | 82 |
| enzon pharmaceuticals | 10 |
| ercole biotech | 2 |
| exiqon | 2 |
| santaris farma | 1 |
2018
| roche innovation center copenhagen | 32 |
| santaris pharma | 5 |
| roche | 4 |
| ercole biotech | 3 |
| exiqon | 1 |
Santaris Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| pharmaceutical composition comprising anti-mirna antisense oligonucleotides | 43 | 2006 |
| micromirs | 42 | 2007 |
| antisense design | 40 | 2002 |
| oligonucleotide conjugates | 33 | 2012 |
| lna antagonists targeting the androgen receptor | 31 | 2007 |
| oligomers and oligomer conjugates | 29 | 2014 |
| antisense oligomers and conjugates targeting pcsk9 | 27 | 2013 |
| potent lna oligonucleotides for the inhibition of hif-1a expression | 25 | 2004 |
| rna antagonist compounds for the modulation of beta-catenin | 23 | 2007 |
| 2'-o,4'-c-methylene bicyclonucleosides | 20 | 1997 |